IP Library Granted Patent US 10,544,444
Granted Patent B2
US 10,544,444 · App. 16/048,000 · Granted Jan 28, 2020

Compositions for in situ labeling of bacterial cell walls with fluorophores and methods of use thereof

Inventors: Michael S. VanNieuwenhze (Bloomington, IN); Edward Hall (Bloomington, IN); Erkin Kuru (Bloomington, IN); Pamela Brown (Columbia, MO); Srinivas Tekkam (Bloomington, IN); Velocity Hughes (Bloomington, IN); Yves Brun (Bloomington, IN)
Assignee: Indiana University Research and Technology Corporation
C12Q1/045C07C271/20C07D311/74C07K9/003C12Q1/025C12Q1/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,544,444
App. No.
16/048,000
Granted
Jan 28, 2020
Kind
B2
Abstract

Disclosed herein are compositions for assessing peptidoglycan biosynthesis in bacteria, for identifying bacteria, and for screening for bacterial cell wall-acting and/or cell wall-disrupting agents via modified D-amino acids and methods of use thereof. Also disclosed are live bacteria having one or more modified D-amino acids as described herein incorporated into peptidoglycan of a bacterial cell wall.

Claims (8)

1. A method of assessing bacterial cell wall synthesis in real time, the method comprising:

providing live bacteria with a first amount of at least one modified amino acid comprising a D-amino acid covalently attached to a fluorescent label selected from the group consisting of C y3B ADA, AF 647 ADA, AF 350 ADA, BADA, FADA, HADA, NADA, TADA, YADA, FDL, HDL, NDL, and TDL, and optionally a second amount of at least one additional modified amino acid comprising a clickable D-amino acid, under conditions sufficient for bacterial cell wall synthesis,

wherein the bacteria covalently incorporate the at least one modified amino acid and optionally the at least one additional modified amino acid into a stem peptide of peptidoglycan of the bacterial cell wall.

2. The method of claim 1 , wherein the first amount and second amount comprise a first concentration and a second concentration, respectively, wherein the first and second concentrations range from about and including 0.10 μM to about and including 1 mM.

3. The method of claim 1 , further comprising detecting a fluorescent signal emitted by the at least one modified amino acid comprising a D-amino acid covalently attached to a fluorescent label, and optionally the at least one additional modified amino acid comprising a clickable D-amino acid incorporated into the stem peptide.

4. The method of claim 1 , wherein the bacteria are Gram-positive bacteria or Gram-negative bacteria.

5. The method of claim 1 , wherein the at least one additional modified amino acid comprising a clickable D-amino acid is selected from the group consisting of EDA and ETDA.

6. The method of claim 1 , wherein the D-amino acid is selected from the group consisting of 3-amino-D-Ala, D-Ala, D-Asp, D-Cys, D-Glu and D-Lys.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2019
From: VANNIEUWENHZE, MICHAEL S.; KURU, ERKIN; BROWN, PAMELA J.; HUGHES, VELOCITY; BRUN, YVES V.; HALL, EDWARD; TEKKAM, SRINIVAS
To: INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
Reel/Frame 048545/0587 →
CONFIRMATORY LICENSE Recorded Dec 11, 2018
From: INDIANA UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 047769/0917 →
Continuity (4)
Continuation 14395815
Provisional Application 61718048 · Oct 24, 2012
Provisional Application 61636640 · Apr 21, 2012
Related Publication 20190024135A1 · Jan 24, 2019